-
Signature
-
/s/ Douglas Barry, Attorney-in-Fact
-
Issuer symbol
-
KNSA
-
Transactions as of
-
09 Feb 2026
-
Net transactions value
-
-$621,884
-
Form type
-
4
-
Filing time
-
11 Feb 2026, 16:38:32 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Ragosa Mark |
CHIEF FINANCIAL OFFICER |
C/O KINIKSA PHARMACEUTICALS INT'L, PLC, 105 PICCADILLY, SECOND FLOOR, LONDON, UNITED KINGDOM |
/s/ Douglas Barry, Attorney-in-Fact |
11 Feb 2026 |
0001835458 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
KNSA |
Class A Ordinary Share |
Options Exercise |
$108,611 |
+8,374 |
+44% |
$12.97 |
27,460 |
09 Feb 2026 |
Direct |
F1 |
| transaction |
KNSA |
Class A Ordinary Share |
Options Exercise |
$41,760 |
+2,471 |
+9% |
$16.90 |
29,931 |
09 Feb 2026 |
Direct |
F1 |
| transaction |
KNSA |
Class A Ordinary Share |
Sale |
$390,535 |
-9,114 |
-30% |
$42.85 |
20,817 |
09 Feb 2026 |
Direct |
F1, F2 |
| transaction |
KNSA |
Class A Ordinary Share |
Sale |
$381,719 |
-8,731 |
-42% |
$43.72 |
12,086 |
09 Feb 2026 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
KNSA |
Share Option |
Options Exercise |
$0 |
-8,374 |
-100% |
$0.000000 |
0 |
09 Feb 2026 |
Class A Ordinary Share |
8,374 |
$12.97 |
Direct |
F1, F4 |
| transaction |
KNSA |
Share Option |
Options Exercise |
$0 |
-2,471 |
-100% |
$0.000000 |
0 |
09 Feb 2026 |
Class A Ordinary Share |
2,471 |
$16.90 |
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: